(Q34637596)

English

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

R K S Phillips

1

1 reference

Europe PubMed Central

3 August 2017

M H Wallace

2

1 reference

Europe PubMed Central

3 August 2017

P M Lynch

3

1 reference

Europe PubMed Central

3 August 2017

E Hawk

4

1 reference

Europe PubMed Central

3 August 2017

G B Gordon

5

1 reference

Europe PubMed Central

3 August 2017

B P Saunders

6

1 reference

Europe PubMed Central

3 August 2017

N Wakabayashi

7

1 reference

Europe PubMed Central

3 August 2017

Y Shen

8

1 reference

Europe PubMed Central

3 August 2017

S Zimmerman

9

1 reference

Europe PubMed Central

3 August 2017

L Godio

10

1 reference

Europe PubMed Central

3 August 2017

M Rodrigues-Bigas

11

1 reference

Europe PubMed Central

3 August 2017

L-K Su

12

1 reference

Europe PubMed Central

3 August 2017

J Sherman

13

1 reference

Europe PubMed Central

3 August 2017

G Kelloff

14

1 reference

Europe PubMed Central

3 August 2017

B Levin

15

1 reference

Europe PubMed Central

3 August 2017

G Steinbach

16

1 reference

Europe PubMed Central

3 August 2017

FAP Study Group

17

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

50

1 reference

Europe PubMed Central

3 August 2017

857-860

1 reference

Europe PubMed Central

3 August 2017

6

1 reference

Europe PubMed Central

3 August 2017

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Outcome of specific COX-2 inhibition in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Mechanism of action of anti-inflammatory drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Upper gastrointestinal cancer in patients with familial adenomatous polyposis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Aspirin use and chronic diseases: a cohort study of the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

7 July 2018

Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

26 October 2018

Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

26 October 2018

Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773237

26 October 2018

Effect of sulindac on small polyps in familial adenomatous polyposis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12010890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12010890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12010890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12010890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.50.6.857

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34637596&oldid=1629708625"